TNF and rheumatoid arthritis: Common DMARDs, such as tumor necrosis factor (TNF) inhibitors and interleukin‐6 (IL‐6) receptor inhibitors, are currently used worldwide for the treatment of RA, but do not control disease progression in all patients.3, 4, 5